Asaio J

• 

  Publication Venue For

  • The Use of the Multisensor HeartLogic Algorithm for Heart Failure Remote Monitoring in Patients With Left Ventricular Assist Devices. 2023
  • Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients..  69:345-349. 2023
  • Multidisciplinary Stroke Pathway for Children Supported With Ventricular Assist Devices..  69:402-410. 2023
  • Enhanced Thrombin Formation in Patients With Ventricular Assist Devices Experiencing Bleeding: Insights From the Multicenter PREVENT Study..  69:278-283. 2023
  • Incidence and Diagnostic Challenges of Bowel Ischemia after Continuous-flow Left Ventricular Assist Device Therapy..  68:676-682. 2022
  • What If the Destination Is Transplant? Outcomes of Destination Therapy Patients Who Were Transplanted..  68:178-183. 2022
  • Time in Therapeutic Range Significantly Impacts Survival and Adverse Events in Destination Therapy Patients..  68:14-20. 2022
  • CARMAT Total Artificial Heart and the Quest to Improve Biventricular Mechanical Support..  67:1109-1110. 2021
  • Renal Considerations in COVID-19: Biology, Pathology, and Pathophysiology..  67:1087-1096. 2021
  • The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation..  67:1159-1162. 2021
  • Optimal Bridging Strategy Post-Ventricular Assist Device Implantation Remains Unclear..  67:e102. 2021
  • Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices..  67:397-404. 2021
  • OptiVol for Volume Assessment in Patients With Continuous Flow Left Ventricular Assist Device..  67:192-195. 2021
  • A Minimally Invasive Approach to HeartMate 3 Implantation for Systemic Ventricular Failure Following the Mustard Procedure for Transposition of the Great Arteries..  66:e62-e63. 2020
  • Acute Kidney Injury, Fluid Overload, and Outcomes in Children Supported With Extracorporeal Membrane Oxygenation for a Respiratory Indication..  66:319-326. 2020
  • Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications..  66:307-313. 2020
  • The HeartMate 6..  66:e46-e49. 2020
  • Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated with a Continuous Left Ventricular Assist Device..  66:160-165. 2020
  • LVAD Outflow Graft Role in Pump Thrombosis..  66:128-131. 2020
  • Prothrombin Complex Concentrate Use in Durable and Short-Term Left Ventricular Assist Device Implantation..  66:e8-e10. 2020
  • Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis..  65:436-441. 2019
  • Different Strokes for Different Folks..  65:205-206. 2019
  • Indications and Outcomes for Temporary Mechanical Circulatory Support in Pediatric Patients with Cardiac Failure..  65:389-394. 2019
  • Intravenous Versus Oral Iron Replacement in Patients with a Continuous-Flow Left Ventricular Assist Device..  65:e90-e91. 2019
  • Assessing Frailty in Patients Undergoing Destination Therapy Left Ventricular Assist Device: Observations from Interagency Registry for Mechanically Assisted Circulatory Support..  64:16-23. 2018
  • Heartmate III Replacement for Recurring Left Ventricular Assist Device Pump Thrombosis..  64:424-426. 2018
  • Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry..  64:218-224. 2018
  • Orthostatic Hypotension in Patients With Left Ventricular Assist Devices: Acquired Autonomic Dysfunction..  64:e40-e42. 2018
  • Physiological and Psychological Stress in Patients Living With a Left Ventricular Assist Device..  64:e172-e180. 2018
  • Vascular Complications and Use of a Distal Perfusion Cannula in Femorally Cannulated Patients on Extracorporeal Membrane Oxygenation..  64:328-333. 2018
  • iPhone in the Management of the Berlin Heart EXCOR Ventricular Assist Device..  64:278-279. 2018
  • ECMO: 40 Years Later..  63:693-694. 2017
  • Efficacy of Flow Monitoring During ECMO..  63:496-500. 2017
  • Inhaled Desmopressin for Refractory Gastrointestinal Bleeding in a Patient With a HeartMate II Left Ventricular Assist Device..  63:e47-e49. 2017
  • Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data..  63:251-256. 2017
  • Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support..  63:536-541. 2017
  • Re: Desmopressin Use in Refractory Gastrointestinal Bleeding in LVAD Patient..  63:e70. 2017
  • Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device..  63:731-735. 2017
  • Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation..  62:232-239. 2016
  • Associations of Preimplant Red Blood Cell Distribution Width with Clinical Outcomes Among Individuals with Left Ventricular Assist Devices..  62:677-683. 2016
  • Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device..  62:291-296. 2016
  • Early Experience with a Novel Cannulation Strategy for Left Ventricular Decompression during Nonpostcardiotomy Venoarterial ECMO..  62:e30-e34. 2016
  • Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device..  62:646-651. 2016
  • Point-of-Care Rapid-Seeding Ventricular Assist Device with Blood-Derived Endothelial Cells to Create a Living Antithrombotic Coating..  62:447-453. 2016
  • Pulmonary Hypertension in the Era of Mechanical Circulatory Support..  62:505-512. 2016
  • Ramp Study Hemodynamics, Functional Capacity, and Outcome in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices..  62:442-446. 2016
  • Circuit oxygenator contributes to extracorporeal membrane oxygenation-induced hemolysis..  61:190-195. 2015
  • Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center..  61:403-409. 2015
  • Relation between pressure and volume unloading during ramp testing in patients supported with a continuous-flow left ventricular assist device..  61:307-312. 2015
  • Outcomes after implantable left ventricular assist device replacement procedures..  60:44-48. 2014
  • Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center..  60:193-198. 2014
  • A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease..  59:668-670. 2013
  • Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation..  59:63-68. 2013
  • Dysphagia in the setting of left ventricular assist device hemolysis..  59:322-323. 2013
  • Allosensitization in cardiac transplantation: shooting at a moving target..  58:548-549. 2012
  • Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients..  56:441-445. 2010